Esperion Therapeutics, Inc. (NASDAQ:ESPR) has 195 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 17,852,427 | 170,226 | 0.96% | $48,915,650.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 17,682,201 | 2,848,410 | 19.20% | $65,424,144.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 14,945,454 | 2,853,005 | 23.59% | $55,298,179.00 |
| Two Seas Capital LP | 31 Mar, 2026 | 11,902,521 | 2,152,797 | 22.08% | $44,039,328.00 |
| Two Seas Capital LP | 31 Mar, 2026 | 11,394,833 | -507,688 | -4.27% | $31,221,842.00 |
| ORBIMED ADVISORS LLC | 31 Mar, 2026 | 10,570,300 | 4,604,802 | 77.19% | $28,962,622.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 10,433,760 | 10,433,760 | 0.00% | $28,588,502.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 9,458,779 | 4,716,697 | 99.46% | $25,917,054.00 |
| WASATCH ADVISORS LP | 31 Mar, 2026 | 9,445,759 | 2,383,902 | 33.76% | $34,949,308.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 7,075,083 | 1,603,472 | 29.31% | $19,385,727.00 |
| State Street Corp | 31 Mar, 2026 | 7,055,794 | 1,125,498 | 18.98% | $19,332,876.00 |
| D. E. Shaw & Co., Inc. | 31 Mar, 2026 | 6,903,483 | 6,694,850 | 3,208.91% | $25,542,887.00 |
| D. E. Shaw & Co., Inc. | 31 Mar, 2026 | 6,540,785 | -362,698 | -5.25% | $17,921,751.00 |
| ORBIMED ADVISORS LLC | 31 Mar, 2026 | 5,965,498 | 5,965,498 | 0.00% | $22,072,343.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 5,955,739 | 218,088 | 3.80% | $16,322,581.00 |
| State Street Corp | 31 Mar, 2026 | 5,930,296 | 1,451,462 | 32.41% | $21,942,095.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 5,737,651 | 986,255 | 20.76% | $21,233,711.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 5,696,432 | 3,987,625 | 233.36% | $21,076,800.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 5,471,611 | 2,950,172 | 117.00% | $20,244,963.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 4,742,082 | 2,503,464 | 111.83% | $17,545,703.00 |